These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12018782)

  • 1. Evaluating subject-treatment interaction when comparing two treatments.
    Gadbury GL; Iyer HK; Allison DB
    J Biopharm Stat; 2001 Nov; 11(4):313-33. PubMed ID: 12018782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential urn designs with elimination for comparing K > or =3 treatments.
    Coad DS; Ivanova A
    Stat Med; 2005 Jul; 24(13):1995-2009. PubMed ID: 15803441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
    Cheng J
    Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.
    Choi L; Dominici F; Zeger SL; Ouyang P
    Stat Med; 2005 Sep; 24(18):2789-805. PubMed ID: 16134133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITT analysis of randomized encouragement design studies with missing data.
    Zhou XH; Li SM
    Stat Med; 2006 Aug; 25(16):2737-61. PubMed ID: 16287216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
    Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
    J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extended general location model for causal inferences from data subject to noncompliance and missing values.
    Peng Y; Little RJ; Raghunathan TE
    Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.
    Zucker DR; Ruthazer R; Schmid CH; Feuer JM; Fischer PA; Kieval RI; Mogavero N; Rapoport RJ; Selker HP; Stotsky SA; Winston E; Goldenberg DL
    J Rheumatol; 2006 Oct; 33(10):2069-77. PubMed ID: 17014022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian inference for randomized clinical trials with treatment failures.
    Shaffer ML; Chinchilli VM
    Stat Med; 2004 Apr; 23(8):1215-28. PubMed ID: 15083479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity analysis for m-estimates, tests, and confidence intervals in matched observational studies.
    Rosenbaum PR
    Biometrics; 2007 Jun; 63(2):456-64. PubMed ID: 17688498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints.
    Masch EJ; Albert JM
    Biom J; 2007 Jun; 49(3):378-93. PubMed ID: 17623343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Med; 2007 Jun; 26(13):2589-603. PubMed ID: 17094074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A likelihood approach to analyzing clinical trial data when treatments favor different outcomes.
    McClure LA; Brown MB
    Contemp Clin Trials; 2006 Aug; 27(4):340-52. PubMed ID: 16426899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smooth bootstrap methods for analysis of longitudinal data.
    Li Y; Wang YG
    Stat Med; 2008 Mar; 27(7):937-53. PubMed ID: 17701950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials.
    Shepherd BE; Gilbert PB; Jemiai Y; Rotnitzky A
    Biometrics; 2006 Jun; 62(2):332-42. PubMed ID: 16918897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.